Carcinogenic activity of anthanthrene on mouse skin

Ercole Cavalieri, P. Mailander, A. Pelfrene

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Dibenzo [cd, jk] pyrene (anthanthrene), considered to be noncarcinogenic, was examined for carcinogenicity in a comparative study with other polycyclic hydrocarbons. Anthanthrene induced benign and malignant epidermal neoplasms in female Swiss mice after repeated skin application. The incidence of these tumors (47%) was lower and the latency longer than those found after benzo[a]pyrene or dibenzo[a,h]pyrene treatment. Since the proportion of malignant neoplasms was similar (60%) in these three groups, the results indicate that anthanthrene is a relatively strong carcinogen. A rationale accounting for previous negative results in percutaneous experiments with this compound is suggested.

Original languageEnglish (US)
Pages (from-to)113-118
Number of pages6
JournalZeitschrift für Krebsforschung und Klinische Onkologie
Volume89
Issue number2
DOIs
StatePublished - Jan 1 1977

Fingerprint

Skin
Cyclic Hydrocarbons
Neoplasms
Benzo(a)pyrene
Carcinogens
anthanthrene
Incidence
dibenzo(a,h)pyrene

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Carcinogenic activity of anthanthrene on mouse skin. / Cavalieri, Ercole; Mailander, P.; Pelfrene, A.

In: Zeitschrift für Krebsforschung und Klinische Onkologie, Vol. 89, No. 2, 01.01.1977, p. 113-118.

Research output: Contribution to journalArticle

@article{f4000cb4c51f41de9f0c5226d15bf232,
title = "Carcinogenic activity of anthanthrene on mouse skin",
abstract = "Dibenzo [cd, jk] pyrene (anthanthrene), considered to be noncarcinogenic, was examined for carcinogenicity in a comparative study with other polycyclic hydrocarbons. Anthanthrene induced benign and malignant epidermal neoplasms in female Swiss mice after repeated skin application. The incidence of these tumors (47{\%}) was lower and the latency longer than those found after benzo[a]pyrene or dibenzo[a,h]pyrene treatment. Since the proportion of malignant neoplasms was similar (60{\%}) in these three groups, the results indicate that anthanthrene is a relatively strong carcinogen. A rationale accounting for previous negative results in percutaneous experiments with this compound is suggested.",
author = "Ercole Cavalieri and P. Mailander and A. Pelfrene",
year = "1977",
month = "1",
day = "1",
doi = "10.1007/BF00308512",
language = "English (US)",
volume = "89",
pages = "113--118",
journal = "Zeitschrift fur Krebsforschung und Klinische Onkologie",
issn = "0171-5216",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Carcinogenic activity of anthanthrene on mouse skin

AU - Cavalieri, Ercole

AU - Mailander, P.

AU - Pelfrene, A.

PY - 1977/1/1

Y1 - 1977/1/1

N2 - Dibenzo [cd, jk] pyrene (anthanthrene), considered to be noncarcinogenic, was examined for carcinogenicity in a comparative study with other polycyclic hydrocarbons. Anthanthrene induced benign and malignant epidermal neoplasms in female Swiss mice after repeated skin application. The incidence of these tumors (47%) was lower and the latency longer than those found after benzo[a]pyrene or dibenzo[a,h]pyrene treatment. Since the proportion of malignant neoplasms was similar (60%) in these three groups, the results indicate that anthanthrene is a relatively strong carcinogen. A rationale accounting for previous negative results in percutaneous experiments with this compound is suggested.

AB - Dibenzo [cd, jk] pyrene (anthanthrene), considered to be noncarcinogenic, was examined for carcinogenicity in a comparative study with other polycyclic hydrocarbons. Anthanthrene induced benign and malignant epidermal neoplasms in female Swiss mice after repeated skin application. The incidence of these tumors (47%) was lower and the latency longer than those found after benzo[a]pyrene or dibenzo[a,h]pyrene treatment. Since the proportion of malignant neoplasms was similar (60%) in these three groups, the results indicate that anthanthrene is a relatively strong carcinogen. A rationale accounting for previous negative results in percutaneous experiments with this compound is suggested.

UR - http://www.scopus.com/inward/record.url?scp=0017725414&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017725414&partnerID=8YFLogxK

U2 - 10.1007/BF00308512

DO - 10.1007/BF00308512

M3 - Article

VL - 89

SP - 113

EP - 118

JO - Zeitschrift fur Krebsforschung und Klinische Onkologie

JF - Zeitschrift fur Krebsforschung und Klinische Onkologie

SN - 0171-5216

IS - 2

ER -